More than 90% of all publications on endotoxin were carried out with endotoxins (lipopolysaccharide, LPS) from enterobacteriaceae. We compared the immune stimulatory potency of 11 different LPSs using human whole blood incubations. While the majority of LPSs induced cytokine release equipotently, a 1000-fold more LPS from Pseudomonas aeruginosa or Vibrio cholerae was still less potent in inducing TNF, IL-1β, IL-10 and IFN-γ though it potently induced nanogram quantities IL-8. All LPSs tested, regardless of the micro-organism, showed Toll-like receptor (TLR)4-dependence, except for the LPSs from P. aeruginosa and V. cholerae, which were both TLR4- and TLR2-dependent. Interestingly, UV-inactivated P. aeruginosa bacteria, although Gram-negative, also showed TLR2- and TLR4-dependence. Repurification of commercial LPS preparations by phenol re-extraction led to a complete loss of the TLR2 dependency, indicating contamination with lipoproteins. In the Limulus amebocyte lysate assay, often performed to exclude contamination in purified water likely to originate from P. aeruginosa, P. aeruginosa LPS was only 2-fold less potent than LPS from S. abortus equi or the assay standard LPS from E. coli. This results in an overestimation of pyrogenic burden by a factor of 500 in the sample when compared with the biological activity of highly purified P. aeruginosa LPS in human whole blood.
Rietschel ET , Brade H.Bacterial endotoxins. Sci Am1992; 267: 54—61.
2.
Vogel SN, Hogan MMThe role of cytokines in endotoxin-mediated host responses. In: Oppenheimer JJ, Shevach (eds). Immunopharmacology. USA:Oxford University Press, 1990: 238—258.
3.
Morrison DC, Ryan JLEndotoxins and disease mechanisms. Annu Rev Med1987; 38: 417—432.
4.
Raetz CRBiochemistry of endotoxins. Annu Rev Biochem1990; 59: 129—170.
5.
Raetz CRBacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles . In: Neidhart FC (ed). Escherichia coli and Salmonella: cellular and molecular biology. American Society for Microbiology, 1996: 48.
6.
Rietschel ET , Kirikae T., Schade UF et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J1994; 8: 217—225.
7.
Rietschel ET , Brade H., Brade L. et al. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity . Prog Clin Biol Res1987; 231: 25—53.
8.
Rietschel ET , Wollenberg HW, Brade H. et al. Structure and function of the lipid A component of lipopolysaccharides. Handbook Endotoxins1984; 1: 187—220.
9.
Tanamoto K., Zahringer U., McKenzie GR et al. Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun1984; 44: 421—426.
10.
Galanos C., Luderitz O., Rietschel ET et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem1985; 148: 1—5.
11.
Loppnow H., Brade L., Brade H. et al. Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol1986; 16: 1263—1267.
12.
Takeda K., Akira S.Toll-like receptors in innate immunity. Int Immunol2005; 17: 1—14.
13.
Watson J., Riblet R.Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J Exp Med1974; 140: 1147—1161.
14.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
15.
Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide . J Exp Med1998; 188: 2091—2097.
16.
Yang RB, Mark MR, Gray A. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature1998; 395: 284—288.
17.
Hirschfeld M., Ma Y., Weis JH, Vogel SN, Weis JJRepurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol2000; 165: 618—622.
18.
Erridge C., Bennett-Guerrero E., Poxton IRStructure and function of lipopolysaccharides. Microbes Infect2002; 4: 837—851.
19.
Lorenz E., Patel DD, Hartung T., Schwartz DAToll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide. Infect Immun2002; 70: 4892—4896.
20.
Werts C., Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol2001; 2: 346—352.
Hirschfeld M., Weis JJ, Toshchakov V. et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun2001; 69: 1477—1482.
23.
Caroff M., Karibian D., Cavaillon JM, Haeffner-Cavaillon N.Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect2002; 4: 915—926.
24.
Netea MG, van Deuren M., Kullberg BJ, Cavaillon JM, Van der Meer JWDoes the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol2002; 23: 135—139.
25.
Hartung T.Die Erfassung von Pyrogenen in einem humanen Vollblutmodell. Altex1995: 70—75.
26.
Morath S., Geyer A., Hartung T.Structure—function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med2001; 193: 393—397.
27.
Hartung T., Docke WD, Gantner F. et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood1995; 85: 2482—2489.
28.
Zughaier SM , Ryley HC, Jackson SKLipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes . Infect Immun1999; 67: 1505—1507.
29.
Mathiak G., Kabir K., Grass G. et al. Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays. Int J Mol Med2003; 11: 41—44.
30.
Erridge C., Pridmore A., Eley A., Stewart J., Poxton IRLipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J Med Microbiol2004; 53: 735—740.
31.
Broady KW, Rietschel ET, Luderitz O.The chemical structure of the lipid A component of lipopolysaccharides from Vibrio cholerae. Eur J Biochem1981; 115: 463—468.
32.
Takayama K., Qureshi N.Chemical structure of lipid A. Bacterial Endotoxic Lipopolysaccharides1992; 1: 43—60.
33.
Loppnow H., Libby P., Freudenberg M., Krauss JH, Weckesser J., Mayer H.Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun1990; 58: 3743—3750.
34.
Qureshi N., Takayama K., Kurtz R.Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun1991; 59: 441—444.
35.
Golenbock DT, Hampton RY, Qureshi N., Takayama K., Raetz CRLipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem1991; 266: 19490—19498.
36.
Schromm AB, Brandenburg K., Loppnow H. et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem2000; 267: 2008—2013.
37.
Soong G., Reddy B., Sokol S., Adamo R., Prince A.TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest2004; 113: 1482—1489.
38.
Adamo R., Sokol S., Soong G., Gomez MI, Prince A.Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and Toll-like receptor 2 as well as Toll-like receptor 5. Am J Respir Cell Mol Biol2004; 30: 627—634.
39.
Sadikot RT, Zeng H., Yull FE et al. p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol2004; 172: 1801—1808.
40.
Faure K., Sawa T., Ajayi T. et al. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins . Respir Res2004; 5: 1.
41.
Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SIHuman Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol2002; 3: 354—359.
42.
Green SK, Schroth MN, Cho JJ, Kominos SK, Vitanza-Jack VBAgricultural plants and soil as a reservoir for Pseudomonas aeruginosa. Appl Microbiol1974; 28: 987—991.
43.
Williams PA , Worsey MJUbiquity of plasmids in coding for toluene and xylene metabolism in soil bacteria: evidence for the existence of new TOL plasmids. J Bacteriol1976; 125: 818—828.
44.
Cappelli G. , Tetta C., Cornia F. et al. Removal of Limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant1993; 8: 1133—1139.
45.
Sundaram S. , Barrett TW, Meyer KB et al. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers. J Am Soc Nephrol1996; 7: 2183—2191.
46.
Lyczak JB, Cannon CL, Pier GBEstablishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect2000; 2: 1051—1060.
47.
Ohman DE, Burns RP, Iglewski BHCorneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Dis1980; 142: 547—555.
48.
Woods DE, Cryz Jr SJ, Friedman RL, Iglewski BHContribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun1982; 36: 1223—1228.
49.
Buret A., Cripps AWThe immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am Rev Respir Dis1993; 148: 793—805.
Lin TJ, Garduno R., Boudreau RT, Issekutz ACPseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J Immunol2002; 169: 4522—4530.
52.
Franzetti F. , Cernuschi M., Esposito R., Moroni M.Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med1992 ; 231: 437—443.
53.
Kielhofner M., Atmar RL, Hamill RJ, Musher DMLife-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis1992; 14: 403—411.
54.
Giamarellos-Bourboulis EJ, Plachouras D., Tzivra A. et al. Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study . Clin Exp Immunol2004; 135: 240—246.
55.
Tanamoto K. , Homma JYEssential regions of the lipopolysaccharide of Pseudomonas aeruginosa responsible for pyrogenicity and activation of the proclotting enzyme of horseshoe crabs. Comparison with antitumor, interferon-inducing and adjuvant activities. J Biochem (Tokyo ) 1982; 91: 741—746.
56.
Laude-Sharp M., Haeffner-Cavaillon N., Caroff M., Lantreibecq F., Pusineri C., Kazatchkine MDDissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from Gram-negative bacteria. Cytokine1990 ; 2: 253—258.
